Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis

Malondialdehyde (MDA)-modified and oxidized low density lipoproteins (LDL) have been demonstrated in atherosclerotic lesions. Elevated titers of autoimmune antibodies specific for MDA-modified LDL predicted the progression of carotid atherosclerosis and of myocardial infarction. Recently, elevated l...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Atherosclerosis 1998-04, Vol.137, p.S33-S38
Hauptverfasser:	Holvoet, Paul, Collen, Désiré
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antioxidants - pharmacology Arteriosclerosis - etiology Arteriosclerosis - prevention & control Atherosclerosis Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Estrogens - pharmacology Humans Lipoproteins Lipoproteins, HDL - physiology Lipoproteins, LDL - blood Lipoproteins, LDL - metabolism Malondialdehyde Medical sciences Oxidation-Reduction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!